Pharmaceutically acceptable liposome-encapsulated busulphan formulations for parenteral administration are provided, as well as a process for their manufacture. The formulations are stable, have improved biodistribution and significantly reduced side effects over those produced by oral administration or parenteral administration of free drug. The formulations are useful as part of bone marrow transplant conditioning regimens.
展开▼
